Usui Yoshihiko, Tsubota Kinya, Agawa Tsuyoshi, Ueda Shunichiro, Umazume Kazuhiko, Okunuki Yoko, Kezuka Takeshi, Yamakawa Naoyuki, Goto Hiroshi
Department of Ophthalmology, Tokyo Medical University Hospital, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):393-399. doi: 10.1007/s00417-016-3541-5. Epub 2016 Nov 22.
To examine the usefulness of measuring immune mediators in aqueous humor samples for differentiating malignant uveal melanoma from benign pigmented intraocular tumors.
Thirteen eyes of 13 patients with uveal melanoma were studied, and 13 eyes of 13 patients with benign pigmented intraocular tumors served as controls. Undiluted samples of aqueous humor were collected, and a cytometric bead array was used to determine the aqueous humor concentrations of 35 immune mediators comprising 14 interleukins (IL), interferon-γ, interferon-γ-inducible protein-10, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, regulated on activation normal T cell expressed and secreted, monokine induced by interferon-γ, basic fibroblast growth factor, Fas ligand, granzyme A, granzyme B, eotaxin, interferon-inducible T-cell alpha chemoattractant, fractalkine, granulocyte macrophage colony-stimulating factor, granulocyte colony-stimulating factor, vascular endothelial growth factor, angiogenin, tumor necrosis factor-α, lymphotoxin-α, and CD40L.
Aqueous humor levels of angiogenin, IL-8, and MCP-1 were significantly higher in eyes with malignant melanoma than in those with benign tumors (p < 0.05).
Angiogenin, IL-8, and MCP-1 levels in aqueous humor may be potential markers for distinguishing malignant uveal melanoma from benign pigmented intraocular tumors, and may be a useful adjunct to histomorphology, diagnostic imaging, and other biomarkers for the diagnosis and appropriate clinical management of malignant uveal melanoma.
研究房水样本中免疫介质检测对于鉴别恶性葡萄膜黑色素瘤与良性色素性眼内肿瘤的作用。
对13例葡萄膜黑色素瘤患者的13只眼进行研究,并以13例良性色素性眼内肿瘤患者的13只眼作为对照。收集未稀释的房水样本,采用细胞计数珠阵列法测定35种免疫介质在房水中的浓度,这些免疫介质包括14种白细胞介素(IL)、干扰素-γ、干扰素-γ诱导蛋白-10、单核细胞趋化蛋白(MCP)-1、巨噬细胞炎性蛋白(MIP)-1α、MIP-1β、活化正常T细胞表达和分泌因子、干扰素-γ诱导的单核因子、碱性成纤维细胞生长因子、Fas配体、颗粒酶A、颗粒酶B、嗜酸性粒细胞趋化因子、干扰素诱导的T细胞α趋化因子、 fractalkine、粒细胞巨噬细胞集落刺激因子、粒细胞集落刺激因子、血管内皮生长因子、血管生成素、肿瘤坏死因子-α、淋巴毒素-α和CD40L。
恶性黑色素瘤患者眼内房水中血管生成素、IL-8和MCP-1的水平显著高于良性肿瘤患者(p < 0.05)。
房水中血管生成素、IL-8和MCP-1水平可能是鉴别恶性葡萄膜黑色素瘤与良性色素性眼内肿瘤的潜在标志物,并且可能是组织形态学、诊断性影像学检查及其他生物标志物的有益辅助手段,有助于恶性葡萄膜黑色素瘤的诊断及适当的临床处理。